graph Evidence gap map comparisons
atezolizumab based treatment
atezolizumab plus nab-paclitaxel atezolizumab plus paclitaxel
mBC - TNBC - L1 - all population 7     
Comparator:  vs Standard of Care (SoC); 
Risk of bias:  low;   some concerns;   high;  NA;